Suppr超能文献

纳米抗体融合的分裂 O-GlcNAcase 对活细胞内的靶蛋白进行去糖基化。

Target protein deglycosylation in living cells by a nanobody-fused split O-GlcNAcase.

机构信息

Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA.

出版信息

Nat Chem Biol. 2021 May;17(5):593-600. doi: 10.1038/s41589-021-00757-y. Epub 2021 Mar 8.

Abstract

O-linked N-acetylglucosamine (O-GlcNAc) is an essential and dynamic post-translational modification that is presented on thousands of nucleocytoplasmic proteins. Interrogating the role of O-GlcNAc on a single target protein is crucial, yet challenging to perform in cells. Herein, we developed a nanobody-fused split O-GlcNAcase (OGA) as an O-GlcNAc eraser for selective deglycosylation of a target protein in cells. After systematic cellular optimization, we identified a split OGA with reduced inherent deglycosidase activity that selectively removed O-GlcNAc from the desired target protein when directed by a nanobody. We demonstrate the generality of the nanobody-fused split OGA using four nanobodies against five target proteins and use the system to study the impact of O-GlcNAc on the transcription factors c-Jun and c-Fos. The nanobody-directed O-GlcNAc eraser provides a new strategy for the functional evaluation and engineering of O-GlcNAc via the selective removal of O-GlcNAc from individual proteins directly in cells.

摘要

O-连接的 N-乙酰葡萄糖胺(O-GlcNAc)是一种必需且动态的翻译后修饰,存在于数千种核细胞质蛋白上。研究 O-GlcNAc 对单个靶蛋白的作用至关重要,但在细胞中进行这项研究具有挑战性。在此,我们开发了一种与纳米抗体融合的分裂 O-GlcNAcase(OGA),作为 O-GlcNAc 清除剂,用于在细胞中选择性糖基化靶蛋白。经过系统的细胞优化,我们鉴定出一种具有降低的固有糖苷酶活性的分裂 OGA,当被纳米抗体靶向时,它可以选择性地从所需的靶蛋白上去除 O-GlcNAc。我们使用针对五个靶蛋白的四个纳米抗体证明了纳米抗体融合的分裂 OGA 的通用性,并使用该系统研究了 O-GlcNAc 对转录因子 c-Jun 和 c-Fos 的影响。纳米抗体靶向的 O-GlcNAc 清除剂为通过直接在细胞中从单个蛋白中选择性去除 O-GlcNAc 来评估和工程化 O-GlcNAc 的功能提供了一种新策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9341/8085020/1bb0084503f4/nihms-1668076-f0006.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验